- Home
- Companies
- usa virginia
- biomark
Show results for
Refine by
Biomark Suppliers In Usa Virginia
5 companies found
based inChantilly, VIRGINIA (USA)
Arthus Biosystems is pleased to provide a series of research reagents and kits to help carry out scientific investigations related to methionine cycle, the critical biochemical pathway that is conserved throughout evolution in all organisms. Our SAM ...
S-adenosylmethionine (SAM) is an important molecule in methionine cycle pathway and one carbon metabolism pathway that are implicated in many metabolic abnomalities found in humans. Methylation index is defined as the ratio of SAM and SAH, which is ...
based inStafford, VIRGINIA (USA)
We are Hyper-accelerate drug and medical device development. Computational models and AI allow to dramatically accelerate the development of new drugs and medical devices, to reduce, refine and replace tests on animals and clinical trials, to ...
A new in silico tool for early screening of compounds multicurrent blocking effects on a population of hiPSC-derived ...
based inManassas, VIRGINIA (USA)
Ceres Nanosciences is a privately held company, located in Northern Virginia, focused on incorporating its proprietary Nanotrap particle technology into a range of diagnostic and research use products and workflows. Nanotrap particles capture, ...
based inMarseille Cedex 9, FRANCE
Veracyte, formerly HalioDx, is a global diagnostics company that improves patient care by answering important clinical questions to inform diagnosis and treatment decisions throughout the patient journey in cancer and other diseases. Our ...
Veracyte offers a unique multiplex tissue imaging and analysis approach combining multiple technologies perfectly adapted to the comprehensive characterization of the tumor microenvironment. ...
based inMidlothian, VIRGINIA (USA)
G3T is developing assets in cardio-metabolic, metabolic and cardiovascular diseases, such as non-alcoholic steatohepatitis (NASH), obesity, diabetes, atherosclerosis, etc. We define our assets as genetically validated drug targets. We partner with ...
We turn biological insights into novel drugs. We use artificial intelligence (AI) and machine learning (ML) to interrogate our data in an unbiased, hypothesis-free manner to drive drug development ...